Loading
Life sciences · Journal article
Intemed International Journal of Research in Integrated Medical Sciences · November 5, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Background: Allergic Rhinitis (AR) presents a widespread immunologic and public health challenge characterized by chronic inflammation of the nasal mucosa, paroxysmal sneezing, rhinorrhea, and nasal congestion. In chronic conditions allergic rhinitis may end up with nasal polyposis. In classical Ayurvedic literature, AR correlates closely with Vataja and Kapha-Vataja Pratishyaya, originating from impaired metabolic fire (Agni), accumulation of metabolic toxins (Ama), and seasonal/daily doshic fluctuations. While conventional pharmacotherapy relies heavily on reactive H1-antihistamines and intranasal corticosteroids, preventive daily health regimens (Dincharya)—specifically low-dose daily nasal oil administration (Pratimarsha Nasya)—offer a sustainable, non-invasive barrier and immunomodulatory intervention. Aim and Objective: To systematically evaluate the biophysical, immunomodulatory, and public health dimensions of incorporating Pratimarsha Nasya into seasonal health awareness strategies for preventing and managing allergic rhinitis at the community primary care level. Methods: A comprehensive review of classical Ayurvedic treatises (Charaka Samhita, Ashtanga Hridaya) alongside modern literature on nasal mucosal physiology, local drug delivery, and seasonal epidemiology was conducted. Clinical parameters evaluated include mucosal barrier function, ciliary beat frequency, Ig E-mediated mast cell stabilization, and patient treatment compliance. Results: Pratimarsha Nasya using lipophilic vehicles (e.g., Anu Taila or processed sesame oil) functions through a dual mechanism: (1) creating a physical lipophilic barrier that prevents allergen binding to Ig E receptors on mucosal mast cells, and (2) conditioning the Schneiderian membrane to preserve optimal mucociliary clearance. Integration into community health models via pre-seasonal Ritu Sandhi transition alerts demonstrates a 70–80% reduction in morning sneezing frequency, lower acute clinic visits, and decreased reliance on long-term rescue antihistamines. Conclusion: Daily Pratimarsha Nasya embedded within Dincharya and aligned with Ritucharya provides a cost-effective, biophysically sound, and scalable preventive framework for allergic rhinitis.